Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-06 · accession 0001209191-23-035266 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-07 | 2023-06-06+ | PCRX | WINSTON ROY | Chief Medical Off | S - Sale | $38.42 | -3,636 | 43.2K | -8% | -$139.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-07 | S | D | 1,857 | $37.87 | 41,356 | D | — | — | (F1) Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2023-06-06 | S | D | 1,779 | $38.99 | 43,213 | D | — | — | (F1) Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. |